| Product Code: ETC8846100 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for motor neurone disease treatment and management is growing due to advancements in neurological research and increased healthcare investments. While there is no cure for MND, pharmaceutical innovations, supportive therapies, and assistive devices are improving patients quality of life. Awareness campaigns and funding for neurodegenerative disease research are also contributing to market growth.
The growing awareness of neurological disorders and advancements in medical research are key drivers of the motor neurone disease (MND) market in the Philippines. Increased investment in healthcare infrastructure and the availability of novel treatment options, such as gene therapies and neuroprotective drugs, are improving patient outcomes. Additionally, collaborations between healthcare institutions and research organizations are accelerating the development of effective MND therapies.
The biggest challenge in the MND market is the lack of awareness and early diagnosis, leading to delayed treatment for many patients. Limited access to specialized healthcare facilities and expensive treatment options further hinder effective management of the disease. Additionally, the absence of local research and development for new therapies slows down progress in offering better treatment options for patients.
The demand for specialized healthcare services for neurodegenerative diseases, including Motor Neurone Disease, is increasing. Opportunities exist in research, development, and distribution of new treatments, assistive devices, and neurological care facilities.
The government plays a crucial role in supporting patients with Motor Neurone Disease (MND) through healthcare policies and medical funding programs. The Department of Health (DOH) works in collaboration with private institutions to enhance research and treatment options for MND. Additionally, laws regarding the accessibility of essential medications and assistive technologies help improve the quality of life for MND patients. PhilHealth, the countrys national health insurance program, also offers financial assistance for medical treatment related to neurodegenerative diseases.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Motor Neurone Disease (MND) Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Motor Neurone Disease (MND) Market - Industry Life Cycle |
3.4 Philippines Motor Neurone Disease (MND) Market - Porter's Five Forces |
3.5 Philippines Motor Neurone Disease (MND) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Philippines Motor Neurone Disease (MND) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Philippines Motor Neurone Disease (MND) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Philippines Motor Neurone Disease (MND) Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Philippines Motor Neurone Disease (MND) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Philippines Motor Neurone Disease (MND) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of motor neurone disease (MND) in the Philippines |
4.2.2 Advances in medical research and technology for the treatment of MND |
4.2.3 Growing healthcare infrastructure and facilities in the Philippines supporting MND patients |
4.3 Market Restraints |
4.3.1 High treatment costs associated with managing MND in the Philippines |
4.3.2 Limited availability of specialized healthcare professionals and facilities for MND patients |
4.3.3 Lack of comprehensive insurance coverage for MND treatments in the Philippines |
5 Philippines Motor Neurone Disease (MND) Market Trends |
6 Philippines Motor Neurone Disease (MND) Market, By Types |
6.1 Philippines Motor Neurone Disease (MND) Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Amyotrophic lateral sclerosis (ALS), 2021- 2031F |
6.1.4 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive bulbar palsy (PBP), 2021- 2031F |
6.1.5 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Progressive muscular atrophy (PMA), 2021- 2031F |
6.1.6 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Primary lateral sclerosis (PLS), 2021- 2031F |
6.2 Philippines Motor Neurone Disease (MND) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Physiotherapy, 2021- 2031F |
6.2.4 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Palliative Care, 2021- 2031F |
6.2.5 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Philippines Motor Neurone Disease (MND) Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Blood test, 2021- 2031F |
6.3.3 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Electromyography (EMG), 2021- 2031F |
6.3.4 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By MRI Scan, 2021- 2031F |
6.3.5 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Transcranial magnetic stimulation (TMS), 2021- 2031F |
6.3.6 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Motor Neurone Disease (MND) Market, By Dosage |
6.4.1 Overview and Analysis |
6.4.2 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Injection, 2021- 2031F |
6.4.4 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Philippines Motor Neurone Disease (MND) Market, By End users |
6.5.1 Overview and Analysis |
6.5.2 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 Philippines Motor Neurone Disease (MND) Market Revenues & Volume, By Others, 2021- 2031F |
7 Philippines Motor Neurone Disease (MND) Market Import-Export Trade Statistics |
7.1 Philippines Motor Neurone Disease (MND) Market Export to Major Countries |
7.2 Philippines Motor Neurone Disease (MND) Market Imports from Major Countries |
8 Philippines Motor Neurone Disease (MND) Market Key Performance Indicators |
8.1 Average time from symptom onset to diagnosis for MND patients in the Philippines |
8.2 Number of clinical trials and research studies focused on MND in the Philippines |
8.3 Availability and accessibility of support services for MND patients and their caregivers in the Philippines |
9 Philippines Motor Neurone Disease (MND) Market - Opportunity Assessment |
9.1 Philippines Motor Neurone Disease (MND) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Philippines Motor Neurone Disease (MND) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Philippines Motor Neurone Disease (MND) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Philippines Motor Neurone Disease (MND) Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.5 Philippines Motor Neurone Disease (MND) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Philippines Motor Neurone Disease (MND) Market - Competitive Landscape |
10.1 Philippines Motor Neurone Disease (MND) Market Revenue Share, By Companies, 2024 |
10.2 Philippines Motor Neurone Disease (MND) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here